亜鉛応答性転写因子MTF-1とCr(VI)毒性 : 6価クロムの発がん性と遺伝子発現抑制作用との関係(誌上シンポジウム)
スポンサーリンク
概要
- 論文の詳細を見る
Chromium exists in many different oxidation states in the environment, Cr(VI) and Cr(III) being the most stable forms. Chromium has been known for over 100 years to be a human carcinogen. The greatest risk of cancer from chromium exposure is associated with Cr(VI). Cr(VI) enters cells via the sulfate anion transporter system and is reduced to intermediate oxidation states, such as Cr(V) and Cr(IV), in the process of forming stable Cr(III) forms. It is known that Cr(VI) affects expression of various genes. Metal responsive element-binding transcription factor-1 (MTF-1) is involved in sensing heavy metal load and the induced transcription of several protective genes, including metallothionein (MT)-I, MT-II, zinc transporter-1, andγ-glutamylcysteine synthetase. Cr(VI) inhibits zinc-induced MT transcription via modifying transactivation potential of MTF-1. However, the molecular mechanism for the Cr(VI)-mediated inhibition of MTF-1 has not been fully elucidated. In this review, I briefly summarize the previous studies and discuss the current status of research on Cr(VI) toxicity and Cr(VI)-mediated inhibition against transcription.
- 2007-12-01
著者
関連論文
- サイトカインによるメタロチオネイン誘導とメタロチオネインによるサイトカイン発現の修飾(誌上シンポジウム)
- 亜鉛応答性転写因子MTF-1とCr(VI)毒性 : 6価クロムの発がん性と遺伝子発現抑制作用との関係(誌上シンポジウム)
- 若手が切り開くMolecular Toxicology 5—化学物質に対する感受性を決定する生体システム—
- 糖尿病網膜症発症の新たな分子機構
- 日-P1-083 自己研鑽・参加型「薬系インターンシップ・ボランティア体験実習」 : 卒後進路決定における効果(薬学教育(その他),ポスター発表,一般演題,再興、再考、創ろう最高の医療の未来)